Veracyte, Inc.
VCYT
$46.41
$0.140.30%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 150.32M | 139.07M | 140.64M | 131.87M | 130.16M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 150.32M | 139.07M | 140.64M | 131.87M | 130.16M |
| Cost of Revenue | 35.39M | 35.21M | 45.35M | 34.81M | 34.23M |
| Gross Profit | 114.93M | 103.87M | 95.28M | 97.07M | 95.93M |
| SG&A Expenses | 59.35M | 50.84M | 46.49M | 54.65M | 61.14M |
| Depreciation & Amortization | 3.16M | 3.29M | 3.33M | 3.33M | 3.29M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 127.34M | 116.43M | 116.02M | 108.76M | 114.93M |
| Operating Income | 22.98M | 22.65M | 24.61M | 23.11M | 15.24M |
| Income Before Tax | 26.52M | 29.97M | 40.63M | 18.89M | 1.25M |
| Income Tax Expenses | 1.03M | 1.27M | -515.00K | -248.00K | 2.23M |
| Earnings from Continuing Operations | 25.49M | 28.71M | 41.15M | 19.14M | -980.00K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 25.49M | 28.71M | 41.15M | 19.14M | -980.00K |
| EBIT | 22.98M | 22.65M | 24.61M | 23.11M | 15.24M |
| EBITDA | 27.82M | 28.08M | 29.91M | 28.38M | 20.73M |
| EPS Basic | 0.32 | 0.36 | 0.52 | 0.24 | -0.01 |
| Normalized Basic EPS | 0.21 | 0.24 | 0.22 | 0.20 | 0.17 |
| EPS Diluted | 0.31 | 0.35 | 0.50 | 0.24 | -0.01 |
| Normalized Diluted EPS | 0.20 | 0.23 | 0.22 | 0.20 | 0.17 |
| Average Basic Shares Outstanding | 79.97M | 79.54M | 79.18M | 78.73M | 78.39M |
| Average Diluted Shares Outstanding | 82.06M | 81.31M | 81.39M | 79.69M | 78.39M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |